IRS rules against 'shell' joint entities
Burda, D.
Modern Healthcare 26(41): 32
1996
ISSN/ISBN: 0160-7480 PMID: 10161907 Document Number: 457912
Document emailed within 1 workday
Related Documents
Bisceglia, M.; Fisher, C.; Suster, S.; Kazakov, D.V.; Cooper, K.; Michal, M. 2004: Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part V: excerpta IIi Pathologica 96(6): 481-495Kemény, A.; Laklia, J.B.; Lencsés, G. 1971: The isolated shell-gland as an experimental object. Transmural potential difference and short-circuit current in the hen's surviving shell-gland Acta Physiologica Academiae Scientiarum Hungaricae 40(3): 313-326
Chazard, E.; Ficheur, Gégoire.; Merlin, Béatrice.; Serrot, E.; Beuscart, Régis. 2009: Adverse drug events prevention rules: multi-site evaluation of rules from various sources Studies in Health Technology and Informatics 148: 102-111
Knopp, W.; Neumann, K. 1993: Indications for diagnostic and therapeutic arthroscopy of "small joints" (elbow, upper ankle joint, wrist joint, hip joint Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 64(3): 163-169
Sahlstedt, B.; Hjelmstedt, A. 1971: Arthrography of the foot joint, subtalus joint and talonavicular joint in children under 2 years Nordisk Medicin 86(37): 1082
Dimopoulos, M.A.; Kastritis, E.; Terpos, E. 2013: Non-secretory myeloma: one, two, or more entities? Oncology 27(9): 930-932
Derbes, S.J.; deShazo, R.D. 1985: Urticaria and angioedema: new insights and new entities Comprehensive Therapy 11(6): 52-59
Kaufman, N.S. 1998: Market dominance of PHO entities is key to achieving PHO success Healthcare Financial Management: Journal of the Healthcare Financial Management Association 52(8): 79-80
Gibowski, M.; Burda, A. 1976: Serum immunoglobulins in selected disease entities Przeglad Dermatologiczny 63(2): 129-132
Piascik, M.M. 1991: Research and development of drugs and biologic entities American Journal of Hospital Pharmacy 48(10 Suppl 1): S4-S13
Sorel, L.; de Biolley, D.; Mechler, L. 1978: Computerized axial tomography and epileptic entities Acta Neurologica Belgica 78(4): 232-241
Armata, J. 1977: Lymphosarcoma and reticulosarcoma in children as separate entities Polski Tygodnik Lekarski 32(3): 117-119
Assanelli, D.; Lewinter, M.; Shabetai, R. 1989: Physiology and physiopathology of the pericardium: 2 underestimated entities Cardiologia 34(8): 671-677
Pallarito, K. 1996: Emerging health entities devouring capital Modern Healthcare 26(50): 68
Mosley, J.W. 1972: Viral hepatitis: a group of epidemiologic entities Canadian Medical Association Journal 106(Suppl): 427-434
Kira, J. 1999: DPB 1 *0501-associated opticomyelitis and atopic myelitis: novel disease entities Rinsho Shinkeigaku 39(1): 19-20
Lv, Y.; Deng, Y.; Liu, M.; Cui, Y.; Lu, Q. 2016: Short Text Classification of EMR Based on Entities and Dependency Parser Zhongguo Yi Liao Qi Xie Za Zhi 40(4): 245-249
Genevay, M.; Coindre, J-Michel.; Guillou, L. 2003: Recent entities in soft tissue tumor pathology. Part 2 Annales de Pathologie 23(2): 135-148
Fearing, M.K.; Spar, M.D.; Kahn, M.J. 1998: Chronic thrombotic thrombocytopenic purpura masquerading as other disease entities Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 150(1): 29-31
Prus, V.šn.; Kardum, Že. 2016: Clinical Entities and Characteristics of Pain in Patients with Rheumatic Diseases Reumatizam 63(Suppl 1): 23-26